Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
815.50    -14.00 (-1.69%)
Bid:
809.00
Ask:
814.00
Spread: 5.00 (0.618%)
Market Cap: £939.24m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

6 Sep 2016 07:00

RNS Number : 0050J
Kainos Group plc
06 September 2016
 

 

ANNOUNCEMENT

6 September 2016

 

Kainos Group plc

("Kainos" or "the Group")

Trading Update

 

- Group maintains guidance for current year -

 

Kainos Group plc (KNOS), a leading UK-based provider of IT, consulting and software solutions, today issues a trading update for the period from 1 April 2016 to 31 August 2016.

 

In the Digital Services division, the Group is experiencing good growth in the public sector. Demand from central and regional government clients continues to strengthen, with notable new contract wins at the National Offender Management Service and the Home Office.

 

Demand for WorkSmart services is strong in the UK and mainland Europe, where the Group has added a number of new enterprise clients, including Tullett Prebon Group Limited. Take-up of the Group's SaaS-based automated testing product, Smart, is solid and the Group continues to invest in both product development and sales and marketing for Smart.

 

The Evolve division continues to make progress with its Integrated Care SaaS platform and has signed a five-year subscription agreement with Hygieia to use Evolve to power its insulin therapy navigation application which aims to help diabetics systematically manage their changing insulin requirements. In the UK, the Evolve for iPad™ offering, which allows clinicians to access electronic patient records on the move, is now in live operation at the South East Coast Ambulance Service. Market conditions in the NHS remain challenging, with limited additional funding to drive demand.

 

Although the outcome of the UK's referendum on Europe ('Brexit') brings with it some uncertainties, the Group continues to see immediate opportunities for growth.

 

Kainos has a robust balance sheet with strong reserves, no debt and strong cash generation, as well as a growing level of recurring revenue. The Group expects results for the full year to be in line with market expectations.

 

 

 

 

-ENDS-

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Brian Gannon, SVP Corporate Development

 

Investec Bank plc +44 20 7597 5970

Dominic Emery/Sebastian Lawrence

Patrick Robb/Matt Lewis

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon/Chris Lane

 

About Kainos

Kainos is a UK-based provider of IT services, consulting and software solutions. It specialises across multiple sectors in the development of digital technology solutions, including software design and agile software development. The Group's Evolve Electronic Medical Records (EMR) product provides a market-leading comprehensive suite of digital services to healthcare providers such as hospitals and community care organisations. Kainos has also developed an automated testing product, Smart, to complement its Workday implementation services.

 

Kainos Group plc (KNOS) is listed on the main market of the London Stock Exchange. At 31 March 2016, it had almost 800 staff working in eight offices in the USA, UK, Ireland, Poland and the Netherlands.

 

For further information please visit the company website: https://www.kainos.com/

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLAMFTMBBMBFF
Date   Source Headline
5th Sep 20187:00 amRNSTrading Update
23rd Aug 20183:40 pmRNSTotal Voting Rights
8th Aug 20182:21 pmRNSDirector/PDMR Shareholding
8th Aug 20182:20 pmRNSDirector/PDMR Shareholding
31st Jul 20183:00 pmRNSAnnual Report and Notice of AGM
24th Jul 20185:41 pmRNSTotal Voting Rights
24th Jul 20183:57 pmRNSDirector/PDMR Shareholding
13th Jul 20187:00 amRNSHolding(s) in Company
4th Jul 20184:51 pmRNSKainos Director/PDMR Shareholding
3rd Jul 201811:54 amRNSKainos Director/PDMR Shareholding
26th Jun 20187:00 amRNSCapital Markets Day
25th Jun 20181:17 pmRNSDirector's Declaration
29th May 20187:00 amRNSPreliminary Results
24th May 20183:08 pmRNSBoard Committee Membership
16th Apr 20187:25 amRNSTrading Update
23rd Mar 20181:06 pmRNSNotification Of Major Holding(s)
23rd Mar 20189:00 amRNSDirector Declaration
22nd Mar 20185:45 pmRNSHolding(s) in Company
23rd Jan 20188:00 amRNSKainos advances digital healthcare transformation
27th Nov 20177:00 amRNSInterim Results
24th Oct 20178:00 amRNSKainos expands its Workday operations in Europe
28th Sep 201711:32 amRNSResult of AGM
4th Sep 20177:00 amRNSTrading Update
17th Aug 20174:32 pmRNSHolding(s) in Company
31st Jul 20173:08 pmRNSAnnual Report 2017 and Notice of AGM
11th Jul 201711:01 amRNSDirector/PDMR shareholdings
6th Jul 20177:00 amRNSFirst Irish customer for Kainos Evolve
3rd Jul 20174:29 pmRNSDirector/PDMR Shareholding
29th Jun 201712:33 pmRNSHolding(s) in Company
30th May 20177:00 amRNSPreliminary Results
12th Apr 20177:00 amRNSTrading Update
27th Mar 201712:01 pmRNSHolding(s) in Company
6th Mar 201710:00 amRNSKainos expands its Workday services in Europe
28th Nov 20167:00 amRNSInterim Results
14th Nov 20167:00 amRNSAppointment of Joint Corporate Broker
2nd Nov 20167:00 amRNSNotice of Results
22nd Sep 20161:45 pmRNSResult of AGM
6th Sep 20167:00 amRNSTrading Update
29th Jul 20165:00 pmRNSAnnual Report 2016 and Notice of AGM
21st Jul 20165:47 pmRNSAward of Shares under SIP and Directors' Dealings
30th Jun 20165:10 pmRNS2016 LTIP Awards - Replacement
30th Jun 20164:25 pmRNS2016 LTIP Awards
13th Jun 20162:27 pmRNSDirector/PDMR Shareholding
9th Jun 20168:00 amRNSKainos appoints new Commercial Client Director
31st May 20167:00 amRNSPreliminary Results
3rd May 20167:00 amRNSNotice of Results
19th Apr 20167:00 amRNSCapital Markets Day
31st Mar 20164:11 pmRNSDirector/PDMR Shareholding
16th Mar 20167:01 amRNSKainos Evolve and InTouch Health Partnership
16th Mar 20167:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.